Neurizon Therapeutics Limited (ASX: NUZ & NUZOA) ("Neurizon" or "the Company"), a clinical-stage biotech company advancing ...

A new paper published on Friday in the journal Forum for Health Economics and Policy by 12 leading health economists explains why the conventional math used to value medicines falls short – and lays ...

mRNA therapeutics hold promise as the next generation of drugs for tissue restoration in regenerative ... manufacturing ...

The European Commission has hit the world's largest maker of generic drugs with a €462.6 million fine for breaching the ...

These plants were widely used as medicine and in cooking. European colonists loved the aroma of the plants ... Stewart's root ...

Aptamer Group plc (AIM: APTA), the developer of novel Optimer ® binders to enable innovation in the life sciences industry, is pleased to announce that a genetic medicines customer has selected ...

"Antibody drugs are advanced medicines designed to target specific disease-causing agents, cancer cells. The technology ...

The lawyer, who used fake IDs and fabricated degrees to prescribe psychiatric drugs, posed as the ‘best specialist in mental ...

Nov. 8, 2024 — Researchers identify a key pathway leading to neurodegeneration in early stages of ALS, hinting at the potential for short-circuiting the progression of the fatal disease if ...

European markets closed lower Tuesday as traders in the region continued to digest the latest slew of earnings reports.